Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period
Authors:
- Arnold D.K. HillAHArnold D.K. Hill
- H. Paul RedmondHRH. Paul Redmond
- Hassan A. NaamaHNHassan A. Naama
- David Bouchier-HayesDBDavid Bouchier-Hayes
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Therapy of Colorectal Carcinoma with Monoclonal Antibodies (MAb17-1A) Alone and in Combination with Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF)Acta Oncologica, 1991
- Flow cytometric analysis of recombinant murine GM‐CSF (rmuGM‐CSF) induced changes in the distribution of specific cell populations in vivoCytometry, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Tumor Growth in Experimental Animals Nutritional Manipulation and Chemotherapeutic Response in the RatAnnals of Surgery, 1980
- Increased superoxide anion production by immunologically activated and chemically elicited macrophagesJournal of Experimental Medicine, 1978
- Experimental Evidence in Support of the Dormant Tumor CellScience, 1959